4//SEC Filing
NAVIDEA BIOPHARMACEUTICALS, INC. 4
Accession 0001144204-14-069235
CIK 0000810509operating
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:35 PM ET
Size
6.9 KB
Accession
0001144204-14-069235
Insider Transaction Report
Form 4
GOLDBERG MICHAEL M
Director
Transactions
- Purchase
Common Stock
2014-11-13$1.06/sh+71,641$75,853→ 261,352 total - Purchase
Common Stock
2014-11-14$1.12/sh+28,359$31,890→ 289,711 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.0499 and $1.0727. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.09 and $1.13. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000810509
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:35 PM ET
- Size
- 6.9 KB